injecting compounded semaglutide Compound Semaglutide 1.75mg - 4 injections
Description
4.4.1 Clinical evidence and limitations An open-label RCT compared 12 weeks of MET versus MET + low-dose liraglutide (1.2 mg/d) as pretreatment before IVF in obese infertile women (with a 4-weeks washout)
The FDA has issued warnings regarding compounded semaglutide due to: Some compounding pharmacies use semaglutide sodium , a form not approved for human injection
Blood sugar spikes after meals are blunted, supporting better glycemic control
These modifications create analytical heterogeneity during LC-MS analysis
Options include dose adjustment, extending time between increases, adding therapy, or reviewing other medications
The unopened original vial is the recommended container until the moment of reconstitution
